Endeavour Sustainable Investment AG
Endeavour  Capital offers private equity (often referred to as venture capital) for  New Zealand companies.
Endeavour Capital is a private equity investment company providing investment funds predominantly in the New Zealand science and technology sectors.  Private equity has been referred to as venture capital in the past.


Advisory Board

Endeavour Capital is fortunate to have access to the services of a world-class advisory board during the evaluation of potential investments and the subsequent growth phase of portfolio companies. Drawing on their international resources, networks and considerable experience, the advisory board adds considerable value in the development of successful portfolio companies.

David Teece

Professor David Teece is an authority on matters of technological change and organizational structure, particularly as it relates to competition policy and intellectual property. He is the Mitsubishi Bank Professor at the Haas School of Business at the University of California, Berkeley, where he also directs the Institute of Management, Innovation and Organization, and is Chairman of the Consortium for Research on Telecommunications Policy.

Professor Teece has a Ph.D. in Economics from the University of Pennsylvania and a MBA from Wharton and has held teaching and research positions at Stanford University and Oxford University. He has testified before Congress on regulatory policy and competition policy, is author of over 100 books and articles, and is the editor of Industrial & Corporate Change (Oxford University Press).

He has also testified before judges, juries, arbitrators, and tribunals in the U.S. and abroad, both on liability and complex valuation and damage issues. Professor Teece has been Chairman of LECG since 1988. He is also a Director of the Atlas Family of Mutual Funds and I-CAP.


Robert Genieser

Mr Genieser joined Vertex as the Managing Director for Europe in 2002. His main focus is to oversee Vertex offices in London, Copenhagen and Marseille, coordinating a team of 15 investment professionals. He also serves as a Partner in Vertex Management Israel.

Prior to joining Vertex, Mr Genieser was a Managing Director of Hambrecht & Quist, which he joined in 1996 in their San Francisco office. While in Silicon Valley, Mr Genieser managed the Firm's wireless, optical and communications software practices. In this capacity, he led the Firm's investments into Chromatis (acquired by Lucent), Paragon Software (acquired by Openwave) and Wavtrace (acquired by Harris). In addition to his investing activities, Mr Genieser executed the IPOs of Portal Software, ONI systems, Corvis, Openwave and INET, amongst others. In the M&A field, Mr Genieser assisted VisionTech on its sale to Broadcom, I-compression on its sale to Globespan, Herrmann Technology on its sale to Lucent, Terayon on its acquisition of Telegate and MoreCom on its sale to Liberate.

Shortly after Hambrecht & Quist's merger with JP Morgan at the end of 2000, Mr Genieser moved to London to run the company's emerging technology practice for Europe and Israel.

Earlier in his career, Mr Genieser worked as a consultant for Bain & Company in San Francisco, where he focused on the telecommunications industry. Prior to receiving his MBA, he worked for Morgan Stanley in both New York and Hong Kong as a member of the corporate restructuring group.

Mr Genieser received an AB (cum Laude) and an MBA from Harvard University.


Shirley Leitch

Shirley Leitch is Deputy Vice Chancellor (Academic) and Professor of Corporate Communication at Swinburne University of Technology in Melbourne, Australia. Dr. Leitch received her PhD from the University of Auckland. She is the founding chair of Online Education Services Ltd, a joint venture with SEEK Ltd. She also serves on the Board of Swinburne Sarawak Holdings SDN BHD, (a joint venture with Pometia, which is owned by the State Government of Sarawak), and on the Board of Swinburne College. Prior to joining Swinburne, she was Dean of Commerce at the University of Wollongong and, in 2008, was elected to the executive committee of the Australian Business Deans Council.

Professor Leitch has previously served as Pro Vice Chancellor of Public Affairs at the University of Waikato in New Zealand, where she held a personal chair in corporate communication. Professor Leitch has held academic posts at the University of Auckland (her alma mater), Massey University and Victoria University of Wellington and is an A-ranked scholar under the New Zealand PBRF research assessment system. She has undertaken a number of senior advisory roles for government and industry, including serving as research leader of the Growth Culture project for the New Zealand Government's Growth and Innovation Advisory Board.

In 2011, Professor Leitch was awarded Discovery Project funding by the Australian Research Council for research on the Mineral Resources Rent Tax. She is also an International researcher on the $1.6m Foundation for Research Science Technology project Building our Productivity: Understanding sustainable collective productivity in NZ firms. Professor Leitch is a highly regarded business academic, who is a member of the Socially Sustainable Technologies flagship within the Institute of Social Research. With more than 100 publications to her name, her work appears in journals including the European Journal of Marketing, Journal of Management Studies, Organization Studies, Human Relations, Discourse Studies, Public Relations Review, Science and Public Policy, Australian Journal of Communication, International Studies in Management and Organization, the Journal of Brand Management and the Journal of Communication Management. Her research is focused on public discourse and change, including science-society engagement and communication, particularly in relation to science and technology.

Dr Sue Foden

Dr Sue Foden holds a number of non executive directorships with both public and private companies and public funding bodies in the biotech and healthcare field. Prior to this Sue held positions in VC, technology transfer and UK biotech.
From 2000 to 2003, she was an Investor Director with the London- based VC firm Merlin Biosciences Ltd. From 1987 to 2000 she was CEO of the Technology transfer company, CRCT, and from 1998 to 2000 also of Cancer Research Ventures [CRV].
From 1983 to 1987 Sue headed up the academic liaison function at what was then Celltech Ltd, dealing with some of the earliest tech transfer deals in the UK and the precedents that these set. Sue studied biochemistry at the Univ of Oxford from where she obtained her MA and DPhil degrees.

 


People
Read more about our
Management Team >>
Associates >>

 

Head office contact details Endeavour Capital
Level Five Wakefield House
90 The Terrace
Wellington
New Zealand
Phone +64 4 499 5140

For further contact details, click here >>

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Email Access Login >>

 

HomeAbout  | Portfolio  | News  | Contact 

Copyright © Endeavour Capital 2008-2010. Site by Oryx Technologies.